BOSTON SCIENTIFIC CORPORATION Funds and ETFs Boston Scientific Corporation
Equities
BSX
US1011371077
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 74.66 USD | +0.15% |
|
+1.32% | +29.15% |
ETFs positioned on Boston Scientific Corporation
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.26% | 12 M€ | +15.09% | - | |
| 1.98% | 1 M€ | +2.21% | - | |
| 1.75% | 17 M€ | +7.73% | - | |
| 1.23% | 2 M€ | -1.17% | - | |
| 1.08% | 14 M€ | -3.66% | ||
| 1.03% | 10 M€ | +6.14% | - | |
| 0.78% | 265 M€ | +7.00% | - | |
| 0.66% | 9 M€ | -.--% | - | |
| 0.62% | 5 M€ | -72.95% | - | |
| 0.47% | 727 M€ | +9.36% | ||
| 0.38% | 25 M€ | +5.10% | - | |
| 0.37% | 2 M€ | +10.27% | ||
| 0.37% | 26 M€ | +16.85% | - | |
| 0.35% | 37 M€ | -.--% | ||
| 0.28% | 1 M€ | +0.04% | ||
| 0.27% | 36 M€ | +3.64% | - | |
| 0.26% | 559 M€ | +14.30% | ||
| 0.26% | 1,848 M€ | +18.39% | - | |
| 0.24% | 8 M€ | +7.30% | - | |
| 0.24% | 744 M€ | +9.63% | ||
| 0.22% | 26 M€ | +21.55% | - | |
| 0.22% | 1,174 M€ | +23.54% | ||
| 0.22% | 273 M€ | -.--% | ||
| 0.22% | 655 M€ | -.--% | - | |
| 0.21% | 6 M€ | +17.98% | - | |
| 0.21% | 121 M€ | +8.42% | - |
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:
- cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%);
- endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ;
- neuromodulation (2%).
The United States account for 59.2% of net sales.
Calendar
2024-05-29
- Bernstein Strategic Decisions Conference
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
74.65
USD
Average target price
81.33
USD
Spread / Average Target
+8.95%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +29.15% | 110B | |
| +12.15% | 227B | |
| +14.90% | 197B | |
| +18.22% | 141B | |
| +0.53% | 64.15B | |
| +16.92% | 53.72B | |
| +6.33% | 51.75B | |
| +10.93% | 45.2B | |
| +5.87% | 37.37B | |
| +27.06% | 32.11B |
- Stock Market
- Equities
- BSX Stock
- Funds and ETFs Boston Scientific Corporation